Evidence map›Paper›PMID 9742142›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1998

A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.

N Ratner, G S Bloom, S T Brady

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Tau: A Signaling Hub Protein.Frontiers in molecular neuroscience · 2021
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mitochondrial trafficking in neurons.Cold Spring Harbor perspectives in biology · 2013
    Review
  10. Review
  11. Cyclin-dependent kinase 5 controls TRPV1 membrane trafficking and the heat sensitivity of nociceptors through KIF13B.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  12. Article
  13. Article
  14. Article
  15. The axonal transport of mitochondria.Journal of cell science · 2012
    Review
  16. Article
  17. Article
  18. Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N RatnerDepartment of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati School of Medicine, Cincinnati, Ohio 45267-0521, USA.
G S Bloom
S T Brady

Funding

MITOGENIC ACTIVITIES IN NEUROFIBROMATOSISR01NS028840 · NINDS · UNIVERSITY OF CINCINNATI · PI NANCY RATNER · 1990 to 2026
$10.1M
MOLECULAR MECHANISMS OF AXONAL TRANSPORTR01NS023868 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BRADY, SCOTT THOMAS · 1986 to 2010
$3.7M
PROPERTIES OF AXONAL TUBULIN RELATED TO NEURONAL GROWTHR01NS023320 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BRADY, SCOTT THOMAS · 1985 to 2003
$1.0M
Molecular Mechanisms of Axonal TransportR56NS023868 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BRADY, SCOTT THOMAS · 2011 to 2011
$554k
NINDS NIH HHS NS23320NINDS NIH HHS NS23868NINDS NIH HHS NS28840NINDS NIH HHS R01 NS023320NINDS NIH HHS R01 NS023868NINDS NIH HHS R01 NS028840NINDS NIH HHS R56 NS023868
6 · The paper itself

Abstract

Proteins that interact with both cytoskeletal and membrane components are candidates to modulate membrane trafficking. The tumor suppressor proteins neurofibromin (NF1) and adenomatous polyposis coli (APC) both bind to microtubules and interact with membrane-associated proteins. The effects of recombinant NF1 and APC fragments on vesicle motility were evaluated by measuring fast axonal transport along microtubules in axoplasm from squid giant axons. APC4 (amino acids 1034-2844) reduced only anterograde movements, whereas APC2 (aa 1034-2130) or APC3 (aa 2130-2844) reduced both anterograde and retrograde transport. NF1 had no effect on organelle movement in either direction. Because APC contains multiple cyclin-dependent kinase (CDK) consensus phosphorylation motifs, the kinase inhibitor olomoucine was examined. At concentrations in which olomoucine is specific for cyclin-dependent kinases (5 microM), it reduced only anterograde transport, whereas anterograde and retrograde movement were both affected at concentrations at which other kinases are inhibited as well (50 microM). Both anterograde and retrograde transport also were inhibited by histone H1 and KSPXK peptides, substrates for proline-directed kinases, including CDKs. Our data suggest that CDK-like axonal kinases modulate fast anterograde transport and that other axonal kinases may be involved in modulating retrograde transport. The specific effect of APC4 on anterograde transport suggests a model in which the binding of APC to microtubules may limit the activity of axonal CDK kinase or kinases in restricted domains, thereby affecting organelle transport.

Indexed as

Adenomatous Polyposis ColiAdenomatous Polyposis Coli ProteinAmino Acid SequenceAnimalsAxonal TransportAxonsCyclin-Dependent KinasesCytoskeletal ProteinsDecapodiformesDose-Response Relationship, DrugEnzyme InhibitorsGTP PhosphohydrolasesHistonesKinetinMicrotubulesMolecular Sequence DataAdenomatous Polyposis Coli ProteinCyclin-Dependent KinasesCytoskeletal ProteinsEnzyme InhibitorsGTP PhosphohydrolasesHistonesKinetinNerve Tissue ProteinsNeurofibromin 1olomoucinePeptide FragmentsProteinsPurinesRecombinant ProteinsNASA Discipline NeuroscienceNon-NASA Center

Identifiers

PMID9742142
PMCPMC6793030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.